Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | The Oxford Centre for Haematology

Paresh Vyas • 15 Jun 2019
EHA 2019
General

Paresh Vyas, MRCP, FRCP, FRCPath, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, discusses the brilliant work of the Oxford Centre for hematology at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Paresh Vyas

2:45
Promising emerging therapies for AML and the challenges that remain
Paresh Vyas • 18 Dec 2023
6:11
First-in-human study of the menin-KMT2A inhibitor JNJ-75276617 in R/R acute leukemias
Paresh Vyas • 18 Dec 2023
1:12
Understanding genetic and non-genetic mechanisms involve in AML disease progression
Paresh Vyas • 24 Apr 2023
0:49
Treatment avenues for patients with R/R FLT3-mutated AML: optimizing FLT3 inhibitors
Paresh Vyas • 24 Apr 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals